This brand name is authorized in Singapore
The drug KANARB PLUS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Fimasartan
UNII 4516BN0T4B - FIMASARTAN POTASSIUM TRIHYDRATE
|
|
Fimasartan, an angiotensin II receptor antagonist with selectivity for the AT1 receptor subtype, is a pyrimidinone-related heterocyclic compound. |
|
2
Hydrochlorothiazide
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C03AA03 | Hydrochlorothiazide | C Cardiovascular system → C03 Diuretics → C03A Low-ceiling diuretics, thiazides → C03AA Thiazides, plain |
| C09CA10 | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: SG | Health Sciences Authority | Identifier(s): 15818P, 15819P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
